Drug therapy: Multidisciplinary management of lung cancer

被引：695

作者：

Spira, A ^{[1
]}

Ettinger, DS ^{[1
]}

机构：

[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 350卷 / 04期

关键词：

D O I：

10.1056/NEJMra035536

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：379 / 392

页数：14

相关论文

共 126 条

[1] AISNER J, 1983, CANCER TREAT REP, V67, P37
[2] ALBERTI W, 1995, BRIT MED J, V311, P899
[3] [Anonymous], 1995, Eur J Surg Oncol, V21, P69
[4] [Anonymous], P AM SOC CLIN ONCOL
[5] [Anonymous], P AM SOC CLIN ONCOL
[6] [Anonymous], P AM SOC CLIN ONCOL
[7] Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: A phase II study in patients with refractory and sensitive disease
Ardizzoni, A
Hansen, H
Dombernowsky, P
Gamucci, T
Kaplan, S
Postmus, P
Giaccone, G
Schaefer, B
Wanders, J
Verweij, J
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) : 2090 - 2096
[8] Argiris A, 2001, CANCER J, V7, P437
[9] BRONCHOGENIC-CARCINOMA - INCIDENCE OF METASTASES TO NORMAL SIZED LYMPH-NODES
ARITA, T
KURAMITSU, T
KAWAMURA, M
MATSUMOTO, T
MATSUNAGA, N
SUGI, K
ESATO, K
[J]. THORAX, 1995, 50 (12) : 1267 - 1269
[10] ARRIAGADA R, 1994, ANTICANCER RES, V14, P333

← 1 2 3 4 5 6 7 8 9 10 →